Summary
This prediction ended on 24.10.22 with a price of €0.64. Massive losses of -93.82% were the result for the BUY prediction by BiotechBee. BiotechBee has 40% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Tricida | - | - | - |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% |
According to BiotechBee what are the pros and cons of Tricida for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Tricida diskutieren
Buy mit Kursziel 25,0